Gastrointestinal Inflammation Associated With CVID

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Gastrointestinal Inflammation Associated With CVID trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (2 shown)

CompletedPhase 1/2

NCT02199496

Study of Safety, Tolerability, and Efficacy of Ustekinumab for Symptomatic Gastrointestinal Inflammation Associated With…

Background: \- Some people with Common Variable Immunodeficiency Disease (CVID) have gastrointestinal inflammation. This can cause diarrhea, weight loss, and n…

United States5 participantsStarted 2015-10-19

Treatment: Stelara (ustekinumab)

CompletedPhase 1

NCT00263237

STA-5326 Meslylate to Treat Gut Inflammation Associated With Common Variable Immunodeficiency

This study will determine whether an experimental medicine, STA-5326 mesylate, is safe to use in patients with common variable immunodeficiency (CVID) who have…

United States10 participantsStarted 2005-12-02

Treatment: STA-5326